BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38738285)

  • 1. The Promise of New Vaccines Against Respiratory Viruses.
    Atmar RL; El Sahly HM
    Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38738285
    [No Abstract]   [Full Text] [Related]  

  • 2. Basic principles and stages in testing new vaccines against respiratory viruses.
    Zykov MP; Zlydnikov DM; Shvetsova EG; Sirotenko EA; Rumovsky VI; Shaposhnikova RP
    Am Rev Respir Dis; 1976 Jan; 113(1):61-6. PubMed ID: 1247217
    [No Abstract]   [Full Text] [Related]  

  • 3. New developments in vaccines against respiratory viruses.
    Wroblewska M
    Curr Opin Investig Drugs; 2008 Aug; 9(8):846-55. PubMed ID: 18666032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New vaccines for respiratory tract ills? Genetic engineering pursues these goals.
    Goldsmith MF
    JAMA; 1989 Oct; 262(15):2055. PubMed ID: 2677420
    [No Abstract]   [Full Text] [Related]  

  • 5. Status of vaccines for respiratory virus infections other than the influenza viruses.
    Mufson MA
    W V Med J; 1979 Apr; 75(4):83-7. PubMed ID: 286473
    [No Abstract]   [Full Text] [Related]  

  • 6. [Respiratory viruses in pediatrics: what's new?].
    Asner SA
    Rev Med Suisse; 2016 Feb; 12(506):358-61. PubMed ID: 27039461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases.
    Altenburg AF; Kreijtz JH; de Vries RD; Song F; Fux R; Rimmelzwaan GF; Sutter G; Volz A
    Viruses; 2014 Jul; 6(7):2735-61. PubMed ID: 25036462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle vaccines against respiratory viruses.
    Adair BM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):405-14. PubMed ID: 20049806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.
    Chan Y; Ng SW; Singh SK; Gulati M; Gupta G; Chaudhary SK; Hing GB; Collet T; MacLoughlin R; Löbenberg R; Oliver BG; Chellappan DK; Dua K
    Life Sci; 2021 Sep; 280():119744. PubMed ID: 34174324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new vaccine against airway infections caused by RS-virus].
    van der Veen J
    Ned Tijdschr Geneeskd; 1979 Jan; 123(1):15-6. PubMed ID: 759961
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of reverse genetics in the development of vaccines against respiratory viruses.
    Marsh GA; Tannock GA
    Expert Opin Biol Ther; 2005 Mar; 5(3):369-80. PubMed ID: 15833074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory viruses.
    Lerner AM
    Ann Intern Med; 1969 Oct; 71(4):860-1. PubMed ID: 4311764
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunization against respiratory virus infections.
    Hobson D
    Mod Trends Immunol; 1967; 2():53-85. PubMed ID: 4298139
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progress of the campaign against acute respiratory viral diseases in children].
    Pringle CR
    Bull World Health Organ; 1987; 65(4):435-9. PubMed ID: 2826029
    [No Abstract]   [Full Text] [Related]  

  • 15. Some recent trends in vaccination against respiratory viruses.
    Tyrrell DA
    Br Med Bull; 1969 May; 25(2):165-71. PubMed ID: 4319087
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combined immunization against influenza and other viral respiratory infections].
    Selivanov AA; Boldasov VK; Kovaleva TP; Shaposhnikova RP; Morozenko MA
    Vestn Akad Med Nauk SSSR; 1970; 25(8):33-7. PubMed ID: 4322340
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of acute lower respiratory illness in the developing world: an assessment of vaccine intervention.
    Karzon DT
    Rev Infect Dis; 1991; 13 Suppl 6():S571-7. PubMed ID: 1862286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in respiratory virus vaccine development.
    Schmidt AC
    Semin Respir Crit Care Med; 2011 Aug; 32(4):527-40. PubMed ID: 21858754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory virus vaccines. V. Field evaluation for efficacy of heptavalent vaccine.
    Weibel RE; Stokes J; Leagus MB; Mascoli CC; Hilleman MR
    Am Rev Respir Dis; 1966 Sep; 94(3):362-79. PubMed ID: 4288226
    [No Abstract]   [Full Text] [Related]  

  • 20. Nanoparticle-Based Vaccines Against Respiratory Viruses.
    Al-Halifa S; Gauthier L; Arpin D; Bourgault S; Archambault D
    Front Immunol; 2019; 10():22. PubMed ID: 30733717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.